BioLargo Granted Expanded Patent Coverage for its AOS Water Treatment Technology

Shawn Dougherty Joins BioLargo’s Subsidiary Clyra Medical Technologies as Chief Revenue Officer
BioLargo’s CupriDyne Technology Proven Effective at Inactivating SARS-CoV-2
BioLargo Subsidiary Clyra Medical’s Clyraguard Product Shows Complete Inactivation of SARS-CoV-2
BioLargo 2019 Annual Report Highlights Record Revenues, New Channel Partnerships, and Commercializat
BioLargo Continuing Operations Through the COVID-19 Crisis


BioLargo, BKT, and Tomorrow Water Set to Launch Joint Venture


BioLargo Reveals Scaled Up Commercial Design for AOS Water Treatment Technology
BioLargo, Inc. Updates The Stock Day Podcast On Commercialization of PFAS Solution
BioLargo, Inc. to Present March 3rd at the 2020 LD Micro Virtual Conference
BioLargo Announces Crowdfunding Offering of Water Subsidiary Opportunity
BioLargo Expands Global Reach, Signs Joint Venture Agreement with BKT & Tomorrow Water
BioLargo Engineering Is Tackling PFAS Head-On With New Treatment Technology
BioLargo Welcomes Water Industry Veteran Tonya Chandler to its Sales and Marketing Team
BioLargo Continues Record-Breaking Revenue Growth
BioLargo Discusses Its 2020 Growth Strategy with the Stock Day Podcast
BioLargo’s CupriDyne Clean Proven Effective in Eliminating Hydrogen Sulfide
BioLargo Awarded 2019 Cleantech Company of the Year by Sustain SoCal
BioLargo to Present at the LD Micro Main Event (XII)
BioLargo Reports Solid Operating Results in Third Quarter as it Breaks Revenue Records
